Clinical Trial

Clinical Evaluation of Arthrocentesis, Combination of Platelet-Rich Plasma and Cyclooxygenase Enzyme-2 Inhibitor in Treatment of Temporo-Mandibular Joint Anterior Displacement

Completed Phase 3
View on ClinicalTrials.gov →
Summary
Clinical Evaluation of Arthrocentesis, Combination of Platelet-Rich Plasma and Cyclooxygenase Enzyme-2 Inhibitor in Treatment of Temporo-Mandibular Joint Anterior Displacement
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-03-05.
Trial Details
NCT Number NCT07463404
Lead Sponsor Suez Canal University
Conditions Temporomandibular Joint Internal Derangement
Enrollment 20 participants
Start Date 2023-12-01
Primary Completion 2025-06-01 (estimated)
Study Completion 2025-11-25 (estimated)
Updated on ClinicalTrials.gov 2026-03-17